✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

In-vivo Imaging Market Research Report: Information By Application (Nuclear Imaging and Optical Imaging), By Technique (Radioisotopes, Biomarkers, Luminescent Proteins Based, and Others), By End Use (Hospitals & Clinics, Imaging Center, Research Organization), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032


ID: MRFR/MED/0296-HCR | 115 Pages | Author: Rahul Gotadki| November 2024

Market Segmentation


Global In-vivo Imaging Application Outlook (USD Billion, 2018-2032)




  • Nuclear imaging




  • Optical imaging




Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




  • Radioisotopes




  • Biomarker




  • Luminescent proteins based




  • Others




Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




  • Hospitals and clinics




  • Imaging centers




  • Research organizations




Global In-vivo Imaging Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • US Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Canada Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Europe Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Germany Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • France Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • UK Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Italy Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Spain Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • China Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Japan Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • India Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Australia Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Middle East Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Africa Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Latin America Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Research Objective

2.4 Assumptions

2.5 Limitations

2.6 Market Structure

2.7 Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porter’s Five Forces Analysis

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global In vivo Imaging Market, by Application

6.1 Introduction

6.2 Nuclear Imaging

6.2.1 PET

6.2.2 SPECT

6.2.3 Others

6.3 Optical Imaging

6.3.1 Fluorescence Imaging

6.3.2 Bioluminescence Imaging

6.3.3 Photoacoustic imaging

6.3.4 Others

7. Global In vivo Imaging Market, by Techniques

7.1 Introduction

7.2 Radioisotopes Based

7.3 Biomarkers Based

7.4 Luminescent Proteins Based

7.5 Others

8. Global In vivo Imaging Market, by End Uses

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Imaging Centers

8.4 Research Organizations

8.5 Others

9. Global In vivo Imaging Market, by Region

9.1 Introduction

9.2 North America

9.2.1 U.S.

9.2.2 Canada

9.3 Europe

9.3.1 Germany

9.3.2 France

9.3.3 Italy

9.3.4 Spain

9.3.5 UK

9.3.6 Rest of Europe

9.4 Asia

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 Saudi Arabia

9.5.2 UAE

9.5.3 South Africa

9.5.4 Algeria

9.5.5 Egypt

10. Competitive Landscape

11 Company Profile

11.1 Bruker

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 MILabs B.V.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 FUJIFILM VisualSonics Inc.

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Development

11.4 Mediso Ltd.

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Development

11.5 LI-COR, Inc.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 Aspect Imaging.

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 TRIFOIL IMAGING

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Developments

11.8 MR Solutions

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Updates

11.8.4 Key Developments

11.9 Biospace Lab S.A.

11.9.1 Overview

11.9.2 Product/Business Segment Overview

11.9.3 Financial Updates

11.9.4 Key Developments

11.10 New England Biolabs.

11.10.1 Overview

11.10.2 Product/Business Segment Overview

11.10.3 Financial Updates

11.10.4 Key Developments

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Global In vivo Imaging Market

13. Appendix

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Preclinical Imaging Market Research Report – Global Forecast till 2032
report-img
AI in Medical Diagnostics Market Research Report — Global Forecast till 2032
report-img
Biophotonics Market Research Report—Global Forecast till 2032
Press Release
pr-img
Increasing Prevalence of Cancer and Increasing R&D Investments in the Imaging Technology to I...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)